Sign inJoin waitlistJoin the waitlist

Sarah Goldberg

Co-Director, Center for Thoracic Cancers · Yale Cancer Center

Credentials: · · · · ·

History

Center for Thoracic Cancers · Yale Cancer Center
Present
Thoracic Oncology Division · Yale Cancer Center
Present
Yale School of Medicine
Present

Dana-Farber Cancer Institute
2009–2012
Dana-Farber Cancer Institute
2010–2012
Yale-New Haven Hospital
2006–2009
Massachusetts General Hospital
2006–2009
Harvard School of Public Health
Icahn School of Medicine at Mount Sinai
2002–2006

Research

Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
The Lancet Oncology · 2016 · First of 21 authors · Corresponding · 837 citations
Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer
Cancer Discovery · 2017 · 648 citations
Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study
The Lancet Oncology · 2016 · 526 citations

RH
Roy Herbst
24 papers
Veronica Chiang
23 papers
Scott Gettinger
17 papers
Harriet Kluger
16 papers
HY
Helena Yu
13 papers
Jonathan Riess
12 papers
Zenta Walther
12 papers
Xiuning Le
11 papers
ZP
Zofia Piotrowska
11 papers
Amit Mahajan
10 papers
Jonathan Goldman
10 papers
KS
Kurt Schalper
10 papers